Literature DB >> 2315872

In vitro and in vivo effects of ribavirin on human respiratory epithelium.

L Y Han1, R Wilson, S Slater, A Rutman, R C Read, N J Snell, P J Cole.   

Abstract

The effects of ribavirin, a broad spectrum antiviral agent, on the structure and function of normal human nasal epithelium have been studied in vitro, as has also the in vivo effect of treatment with nebulised ribavirin on nasal mucociliary clearance of saccharin in four patients. Ciliary beat frequency was measured by a photometric technique, and changes in epithelial and ciliary ultrastructure were assessed by transmission electron microscopy. Ribavirin solution at the recommended concentration of 20 mg/ml had no adverse effects on ciliary activity in vitro; at concentrations of 50 mg/ml and above it slowed ciliary beating significantly and at 60 mg/ml caused ciliostasis associated with epithelial disruption. Nasal inhalation of ribavirin at 60 mg/ml for up to 20 minutes, however, did not slow nasal mucociliary clearance, nor did it adversely affect the ciliary beating or structure of nasal ciliated epithelium examined in vitro immediately after inhalation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315872      PMCID: PMC462315          DOI: 10.1136/thx.45.2.100

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  pH effects on ciliomotility and morphology of respiratory mucosa.

Authors:  B Holma; M Lindegren; J M Andersen
Journal:  Arch Environ Health       Date:  1977 Sep-Oct

2.  Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols.

Authors:  J R Balmes; J M Fine; D Christian; T Gordon; D Sheppard
Journal:  Am Rev Respir Dis       Date:  1988-07

3.  Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells.

Authors:  M Kaliner; K F Austen
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

4.  Non-invasive sampling of nasal cilia for measurement of beat frequency and study of ultrastructure.

Authors:  J Rutland; P J Cole
Journal:  Lancet       Date:  1980-09-13       Impact factor: 79.321

5.  Efficacy of a saccharin test for screening to detect abnormal mucociliary clearance.

Authors:  P Stanley; L MacWilliam; M Greenstone; I Mackay; P Cole
Journal:  Br J Dis Chest       Date:  1984-01

6.  Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants.

Authors:  C K Luk; M J Dulfano
Journal:  Clin Sci (Lond)       Date:  1983-04       Impact factor: 6.124

7.  Ribavirin small-particle aerosol treatment of influenza.

Authors:  V Knight; H W McClung; S Z Wilson; B K Waters; J M Quarles; R W Cameron; S E Greggs; J M Zerwas; R B Couch
Journal:  Lancet       Date:  1981-10-31       Impact factor: 79.321

8.  Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.

Authors:  R E Schoeffel; S D Anderson; R E Altounyan
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-14

9.  Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Authors:  C B Hall; J T McBride; E E Walsh; D M Bell; C L Gala; S Hildreth; L G Ten Eyck; W J Hall
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

10.  Ribavirin aerosol treatment of influenza B virus infection.

Authors:  H W McClung; V Knight; B E Gilbert; S Z Wilson; J M Quarles; G W Divine
Journal:  JAMA       Date:  1983-05-20       Impact factor: 56.272

View more
  1 in total

1.  Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study.

Authors:  C Agustí; A Xaubet; E Ballester; A Alarcón; C Picado
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.